United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - ketorolac trometamol - eye drops - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - ketorolac trometamol - eye drops - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - ketorolac trometamol - eye drops - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - ketorolac trometamol - eye drops - 5mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - ketorolac trometamol - eye drops - 5mg/1ml

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - ketorolac tromethamine 5 mg in 1 ml - indications and usage acular® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. acular® ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction. contraindications acular® ophthalmic solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation.

European Union - English - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dexamethasone - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex is indicated for the treatment of adult patients with macular oedema following either branch retinal-vein occlusion (brvo) or central retinal-vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as noninfectious uveitis.ozurdex is indicated for the treatment of adult patients with visual impairment due to diabetic macular oedema (dme) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

france medical pty ltd -